Gain Therapeutics, Inc. (GANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

1.2800

+0.0300

(+2.40%)

At close: 04:00PM EDT

1.2200

-0.06

(-4.69%)

After hours:

06:17PM EDT

Insider Roster

Individual or Entity	Most Recent Transaction	Date	Shares Owned as of Transaction Date
ALDER MATTHIAS Chief Executive Officer	Conversion of Exercise of derivative security	Mar 25, 2024	21,140
CALABRESE SALVATORE Chief Financial Officer	Purchase	May 18, 2022	3,000
RICHMAN ERIC I. Director	Conversion of Exercise of derivative security	Sept 19, 2023	287,458
RILEY JEFFREY SCOTT Director	Purchase	Mar 27, 2024	30,000
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.